FDA Orange Book

Is there a generic for Cuvrior?

Cuvrior contains trientine tetrahydrochloride. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Cuvrior (trientine tetrahydrochloride). The Orange Book shows its last listed patent expires May 3, 2039 and its last listed exclusivity ends April 28, 2029.

Run it in Rivvi

Map Cuvrior and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Cuvrior products in the Orange Book

Cuvrior products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oral300MGMarketed (Rx)None0None

NDA 215760, held by ORPHALAN SA. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Cuvrior patents

Patents listed for Cuvrior
PatentExpiresCoversUse codeNDA
12358862May 3, 2039Drug substance, Drug productU-4262215760
12358861May 3, 2039Drug substance, Drug productU-4262215760
11072577May 3, 2039Method of useU-3370215760
12662445May 3, 2039Drug substance, Drug productU-4262215760
10988436May 3, 2039Drug substanceNone215760

Cuvrior exclusivity

Exclusivity listed for Cuvrior
CodeMeaningExpiresNDA
ODE-401Orphan drug exclusivityApril 28, 2029215760

Cuvrior NDC codes

Questions

Is there a generic for Cuvrior?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Cuvrior (trientine tetrahydrochloride). The Orange Book shows its last listed patent expires May 3, 2039 and its last listed exclusivity ends April 28, 2029.

What is the generic name for Cuvrior?

The active ingredient in Cuvrior is trientine tetrahydrochloride, per the FDA Orange Book.

When does the Cuvrior patent expire?

The last patent listed for Cuvrior in the Orange Book expires May 3, 2039. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Cuvrior and Trientine Tetrahydrochloride

Try it on your own data today.

Free to start. Most teams are using it the same day.